Jason V Coloma insider trades

Open-market stock purchases and sales by Jason V Coloma, Chief Executive Officer at Maze Therapeutics, Inc, from SEC Form 4 filings since Jun 8, 2016.

Recent trades

DateStockTradeValue
Sep 3, 2026MAZE Maze Therapeutics, IncSold$293K
Sep 3, 2026MAZE Maze Therapeutics, IncSold$3.3K
Sep 2, 2026MAZE Maze Therapeutics, IncSold$260K
Sep 2, 2026MAZE Maze Therapeutics, IncSold$37.3K
Sep 1, 2026MAZE Maze Therapeutics, IncSold$68.2K
Sep 1, 2026MAZE Maze Therapeutics, IncSold$839K
Sep 1, 2026MAZE Maze Therapeutics, IncBought (not open market)—
Aug 3, 2026MAZE Maze Therapeutics, IncSold$4.2K
Aug 3, 2026MAZE Maze Therapeutics, IncSold$810K
Aug 3, 2026MAZE Maze Therapeutics, IncSold$65.2K
Aug 3, 2026MAZE Maze Therapeutics, IncSold$43.4K
Jun 23, 2026MAZE Maze Therapeutics, IncSold$622K
Jun 22, 2026MAZE Maze Therapeutics, IncSold$50.8K
Jun 22, 2026MAZE Maze Therapeutics, IncSold$53K
Jun 1, 2026MAZE Maze Therapeutics, IncSold$14.5K
Jun 1, 2026MAZE Maze Therapeutics, IncSold$160K
May 26, 2026MAZE Maze Therapeutics, IncSold$666K
May 22, 2026MAZE Maze Therapeutics, IncSold$117K
May 22, 2026MAZE Maze Therapeutics, IncSold$64.4K
May 15, 2026MAZE Maze Therapeutics, IncSold$47.4K
May 15, 2026MAZE Maze Therapeutics, IncSold$3K
Mar 2, 2026MAZE Maze Therapeutics, IncBought (not open market)—
Mar 2, 2026MAZE Maze Therapeutics, IncBought (not open market)—

Companies traded

  • MAZE Maze Therapeutics, Inc: 20 sales, last Sep 3, 2026
  • CRVS Corvus Pharmaceuticals, Inc: other filings, last Jun 8, 2016

Get free alerts when Jason V Coloma files a new trade →